Showing results (71-80 of 359) with videos related to
Sort By:
Pageof 36
Current Protein & Peptide Science|December 9, 2020
Deciphering the Neuroprotective Role of Glucagon-like Peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future DirectionsKeshav Mehta, Tapan Behl, Arun Kumar, et al.Molecular Biology Reports|September 5, 2020
Molecular insights into therapeutic promise of targeting of Wnt/β-catenin signaling pathway in obesityPriya Nijhawan, Tapan Behl, Simona Bungau, et al.Molecular Neurobiology|November 20, 2020
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's DiseaseTapan Behl, Ishnoor Kaur, Aayush Sehgal, et al.Molecular Biology Reports|March 25, 2021
Exploring the recent molecular targets for diabetes and associated complicationsAmit Gupta, Tapan Behl, Aayush Sehgal, et al.Molecular Biology Reports|January 3, 2021
Unfolding Nrf2 in diabetes mellitusTapan Behl, Ishnoor Kaur, Aayush Sehgal, et al.Environmental Science and Pollution Research International|June 3, 2021
Targeting cellular batteries for the therapy of neurological diseasesArpita Arora, Tapan Behl, Aayush Sehgal, et al.Neurochemical Research|June 2, 2021
Elucidating the Possible Role of FoxO in DepressionTarapati Rana, Tapan Behl, Aayush Sehgal, et al.Environmental Science and Pollution Research International|May 30, 2021
Connecting the dots between mitochondrial dysfunction and Parkinson's disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severityIshnoor Kaur, Tapan Behl, Aayush Sehgal, et al.Life Sciences|September 22, 2020
Ubiquitination in rheumatoid arthritisTapan Behl, Swati Chadha, Monika Sachdeva, et al.CNS & Neurological Disorders Drug Targets|August 20, 2021
Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's DiseaseAnkita Sood, Ravi Goyal, Harshdeep Singh, et al.Pageof 36